| Sara Badano, MD | |
|
433 Mcalister Rd, Lincolnton, NC 28092-4147 | |
| (980) 212-6018 | |
| Not Available |
| Full Name | Sara Badano |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 433 Mcalister Rd, Lincolnton, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912961079 | NPI | - | NPPES |
| Entity Name | Carolinas Physicians Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477878890 PECOS PAC ID: 3375449655 Enrollment ID: O20031219000455 |
News Archive
The University of Houston (UH) received a $2.4 million grant to fund the most promising young cancer researchers who are working at the cutting-edge of a new multidisciplinary approach to fighting cancer.The award is part of the latest round of grant disbursements from the Cancer Prevention and Research Institute of Texas (CPRIT), which oversees the state's new billion-dollar war on cancer. It is UH's second CPRIT grant, and the first in the science and engineering fields.
Soon you may no longer have to worry about how long your dental repairs will last. A new dental reconstruction material developed in Sweden offers unprecedented improvements over existing acrylate-based fillers.
A new study published in Science confirms that SARS-CoV-2 has mutated in a way that's enabled it to spread quickly around the world, but the spike mutation may also make the virus more susceptible to a vaccine.
Abraxis BioScience, Inc., a fully integrated biotechnology company, announced that the updated survival findings from a Phase I/II clinical trial evaluating the chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine for first-line treatment of patients with metastatic pancreatic cancer will be discussed during a keynote address on April 20 at the 101st Annual Meeting of the American Association for Cancer Research (AACR) being held in Washington, D.C.
› Verified 8 days ago
| Entity Name | Hospice & Palliative Care Charlotte Region |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548398720 PECOS PAC ID: 1355331208 Enrollment ID: O20040513001131 |
News Archive
The University of Houston (UH) received a $2.4 million grant to fund the most promising young cancer researchers who are working at the cutting-edge of a new multidisciplinary approach to fighting cancer.The award is part of the latest round of grant disbursements from the Cancer Prevention and Research Institute of Texas (CPRIT), which oversees the state's new billion-dollar war on cancer. It is UH's second CPRIT grant, and the first in the science and engineering fields.
Soon you may no longer have to worry about how long your dental repairs will last. A new dental reconstruction material developed in Sweden offers unprecedented improvements over existing acrylate-based fillers.
A new study published in Science confirms that SARS-CoV-2 has mutated in a way that's enabled it to spread quickly around the world, but the spike mutation may also make the virus more susceptible to a vaccine.
Abraxis BioScience, Inc., a fully integrated biotechnology company, announced that the updated survival findings from a Phase I/II clinical trial evaluating the chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine for first-line treatment of patients with metastatic pancreatic cancer will be discussed during a keynote address on April 20 at the 101st Annual Meeting of the American Association for Cancer Research (AACR) being held in Washington, D.C.
› Verified 8 days ago
| Entity Name | Optimed Hospitalists, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235449125 PECOS PAC ID: 8022204171 Enrollment ID: O20101201000378 |
News Archive
The University of Houston (UH) received a $2.4 million grant to fund the most promising young cancer researchers who are working at the cutting-edge of a new multidisciplinary approach to fighting cancer.The award is part of the latest round of grant disbursements from the Cancer Prevention and Research Institute of Texas (CPRIT), which oversees the state's new billion-dollar war on cancer. It is UH's second CPRIT grant, and the first in the science and engineering fields.
Soon you may no longer have to worry about how long your dental repairs will last. A new dental reconstruction material developed in Sweden offers unprecedented improvements over existing acrylate-based fillers.
A new study published in Science confirms that SARS-CoV-2 has mutated in a way that's enabled it to spread quickly around the world, but the spike mutation may also make the virus more susceptible to a vaccine.
Abraxis BioScience, Inc., a fully integrated biotechnology company, announced that the updated survival findings from a Phase I/II clinical trial evaluating the chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine for first-line treatment of patients with metastatic pancreatic cancer will be discussed during a keynote address on April 20 at the 101st Annual Meeting of the American Association for Cancer Research (AACR) being held in Washington, D.C.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sara Badano, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Sara Badano, MD 433 Mcalister Rd, Lincolnton, NC 28092-4147 Ph: (980) 212-6018 |
News Archive
The University of Houston (UH) received a $2.4 million grant to fund the most promising young cancer researchers who are working at the cutting-edge of a new multidisciplinary approach to fighting cancer.The award is part of the latest round of grant disbursements from the Cancer Prevention and Research Institute of Texas (CPRIT), which oversees the state's new billion-dollar war on cancer. It is UH's second CPRIT grant, and the first in the science and engineering fields.
Soon you may no longer have to worry about how long your dental repairs will last. A new dental reconstruction material developed in Sweden offers unprecedented improvements over existing acrylate-based fillers.
A new study published in Science confirms that SARS-CoV-2 has mutated in a way that's enabled it to spread quickly around the world, but the spike mutation may also make the virus more susceptible to a vaccine.
Abraxis BioScience, Inc., a fully integrated biotechnology company, announced that the updated survival findings from a Phase I/II clinical trial evaluating the chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine for first-line treatment of patients with metastatic pancreatic cancer will be discussed during a keynote address on April 20 at the 101st Annual Meeting of the American Association for Cancer Research (AACR) being held in Washington, D.C.
› Verified 8 days ago
Shujaat A Khan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 433 Mcalister Rd, Lincolnton, NC 28092 Phone: 704-574-4746 | |
Jennifer Lynn Herington, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 433 Mcalister Rd, Lincolnton, NC 28092 Phone: 704-574-4746 | |
David Stephen Meyer, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 607 S Generals Blvd, Lincolnton, NC 28092 Phone: 704-736-9188 Fax: 704-736-9667 | |
Allison Marie Prinz, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 447 Mcalister Rd, Ste 1600, Lincolnton, NC 28092 Phone: 980-212-5100 | |
Ramon Martinez Anastacio, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 447 Mcalister Rd, Ste 3200, Lincolnton, NC 28092 Phone: 980-212-6300 | |
Kwabena Osei-boateng, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 447 Mcalister Rd, Ste 1600, Lincolnton, NC 28092 Phone: 980-212-5100 | |
Godofredo I Garcia, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 433 Mcalister Rd, Lincolnton, NC 28092 Phone: 980-212-6018 Fax: 980-487-3294 |